These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3849413)

  • 21. The antiprogesterone steroid RU 486: a short pharmacological and clinical review, with emphasis on the interruption of pregnancy.
    Garfield RE; Baulieu EE
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):207-21. PubMed ID: 3297023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiprogesterone activity of RU 486 and its contragestive and other applications.
    Baulieu EE; Ulmann A
    Hum Reprod; 1986 Feb; 1(2):107-10. PubMed ID: 3031127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor.
    Baulieu EE
    Science; 1989 Sep; 245(4924):1351-7. PubMed ID: 2781282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interruption of early pregnancy by an anti-progestational compound, RU 486.
    Haspels AA
    Eur J Obstet Gynecol Reprod Biol; 1985 Sep; 20(3):169-75. PubMed ID: 4054413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L; Odlind V
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
    Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E
    Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy termination with a high and medium dosage regimen of RU 486.
    Shoupe D; Mishell DR; Brenner PF; Spitz IM
    Contraception; 1986 May; 33(5):455-61. PubMed ID: 3757511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy.
    Swahn ML; Gottlieb C; Green K; Bygdeman M
    Contraception; 1990 May; 41(5):461-73. PubMed ID: 2347194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy.
    Howell RJ; Olajide F; Teisner B; Grudzinskas G; Chard T
    Fertil Steril; 1989 Jul; 52(1):66-8. PubMed ID: 2744189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone antagonists on the horizon.
    Spitz IM; Bardin CW
    Clin Obstet Gynecol; 1989 Jun; 32(2):403-13. PubMed ID: 2663280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fertility control with RU 486.
    Ulmann A; Dubois C; Philibert D
    Horm Res; 1987; 28(2-4):274-8. PubMed ID: 3331378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination of pregnancy.
    Urquhart DR; Bahzad C; Templeton AA
    Hum Reprod; 1989 Feb; 4(2):202-3. PubMed ID: 2918074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contragestion by the progesterone antagonist RU 486: a novel approach to human fertility control.
    Baulieu EE
    Contraception; 1987; 36 Suppl():1-5. PubMed ID: 2824124
    [No Abstract]   [Full Text] [Related]  

  • 36. Mifepristone (RU486): a review.
    Mahajan DK; London SN
    Fertil Steril; 1997 Dec; 68(6):967-76. PubMed ID: 9418681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antiprogesterone steroid RU-486 does not impair gonadotropin-stimulated luteal adenylyl cyclase activity or gonadotropin release by pituitary cells.
    Rojas FJ; O'Conner JL; Asch RH
    J Steroid Biochem; 1985 Dec; 23(6A):1053-8. PubMed ID: 3937946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
    Swahn ML; Bygdeman M
    Acta Obstet Gynecol Scand; 1989; 68(4):293-300. PubMed ID: 2694744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiprogesterones.
    Norman J
    Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control.
    Couzinet B; Schaison G
    Drugs; 1988 Mar; 35(3):187-91. PubMed ID: 3286211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.